Statins are the go-to medications for lowering "bad" LDL cholesterol, reducing the risk of cardiovascular disease and ...

Jarvik says his role in Lipitor ad currently being investigated is educational. Jan. 16, 2008 — -- Robert Jarvik, the inventor of the artificial heart, is at the center of a congressional ...

Pfizer Inc PFE has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor. What Happened: The lawsuit, filed by wholesale drug distributors, accused Pfizer of ...

High doses of the cholesterol-lowering drug Lipitor were no better at preventing major heart problems than regular doses of rival Zocor, according to the latest study on efforts to aggressively treat ...

For months, Dr. Robert Jarvik, who invented the artificial heart, has been the face millions of Americans see every night, in a high-budget series of ads. "After my father died, I devoted my life to ...

India's largest maker of generic drugs won approval Wednesday to sell a generic version of cholesterol blockbuster Lipitor. The world's top-selling drug ever lost U.S. patent protection earlier in the ...

Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved ...

When it was in development, the cholesterol-lowering medicine was viewed as such an also-ran it almost didn't make it into patient testing. By the time Lipitor went on sale in early 1997, it was the ...

For decades, statins have been the quiet workhorses of cardiology, cutting heart attack and stroke risk for millions while leaving a stubborn puzzle unsolved: why do some patients feel their muscles ...

The FDA said Ranbaxy has agreed to stop manufacturing Atorvastatin. Nov. 30, 2012 — -- Ranbaxy Pharmaceuticals Inc., the company that makes a generic version of the cholesterol-controlling ...

Amgen, Inc was a big winner coming out of the American College of Cardiology Conference, where it presented five new phase 3 studies on evolocumab, part of the likely next generation of cholesterol ...

BOSTON (MarketWatch) -- Pfizer Inc. on Wednesday won a key battle in its fight to fend off overseas generic competition for Lipitor, the pharmaceutical giant's blockbuster cholesterol-lowering drug. A ...